Essure
Device Womens Health
PDI 00888853030517
General payments
$525,265
Research payments
$1,999,495
Through program year 2025, $525,265 in general payments and $1,999,495 in research payments were reported against Essure (Womens Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $78,317 | 10 |
| 2025 | Research | $232,826 | 93 |
| 2024 | General | $214,370 | 20 |
| 2024 | Research | $400,463 | 199 |
| 2023 | General | $222,629 | 26 |
| 2023 | Research | $601,464 | 256 |
| 2022 | General | $9,950 | 14 |
| 2022 | Research | $764,741 | 326 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
70 general · 874 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.